Dendrimer-Based Gene Delivery Systems: Administration Routes and In Vivo Evaluation

Dendrimer-Based Drug Delivery Systems: From Theory to Practice

Volumn , Issue , 2012, Pages 329-354

  Santander Ortega, M J ^a   Uchegbu, I F ^b   Schatzlein A G ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Dendrimer based gene delivery and in vivo evaluation, a challenge; Dendrimers and dendriplexes, and dendrimer DNA binding affinities; Dendrimers, promising synthetic vectors in genetic therapies; Intravenous, nucleic acids in vivo, the most challenging; Vector design, dendrimer generation and vector transfection efficiency

Indexed keywords

EID: 84886207158     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118275238.ch9     Document Type: Chapter

References (165)

1. Almutairi A., et al. (2009). Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc. Natl. Acad. Sci. U.S.A., 106, 685-690.
2. Nanjwade, B.K., et al. (2009). Dendrimers: emerging polymers for drug-delivery systems. Eur. J. Pharm. Sci., 38, 185-196.
3. Tomalia, D.A. (2005). Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog. Polymer Sci. (Oxford), 30, 294-324.
4. DeMattei, C.R., Huang, B.H., Tomalia, D.A. (2004). Designed dendrimer syntheses by self-assembly of single-site, ssDNA functionalized dendrons. Nano Lett., 4, 771-777.
5. Svenson, S., Tomalia, D.A. (2005). Dendrimers in biomedical applications-Reflections on the field. Adv. Drug Deliv. Rev., 57, 2106-2129.
6. Bai, S.H., Thomas, C., Ahsan, F. (2007). Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin. J. Pharm. Sci., 96, 2090-2106.
7. Esfand, R., Tomalia, D.A. (2001). Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today, 6, 427-436.
8. Sakthivel, T., Florence, A.T. (2003). Dendrimers and dendrons: facets of pharmaceutical nanotechnology. Drug Delivery Technol., 3, 73-78.
9. Parekh, H.S. (2007). The advance of dendrimers-a versatile targeting-platform for gene/ drug delivery. Curr. Pharm. Des., 13, 2837-2850.
10. Norden, B., et al. (2008). DNA condensation by PAMAM dendrimers: self-assembly characteristics and effect on transcription. Biochemistry, 47, 1732-1740.
11. Kukowska-Latallo, J.F., et al. (1996). Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc. Natl. Acad. Sci. U.S.A., 93, 4897-4902.
12. Bielinska, A.U., Kukowska-Latallo, J.F., Baker, J.R. (1997). The interaction of plasmid DNAwith polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim. Biophys. Acta, 1353, 180-190.
13. Tang, M.X., Szoka, F.C. (1997). The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther., 4, 823-832.
14. Raviña, M., et al. (2010). Knocking down gene expression with dendritic vectors. Mini Rev. Med. Chem., 10, 73-86.
15. Mezei, A., et al. (2007). Effect of mixing on the formation of complexes of hyperbranched cationic polyelectrolytes and anionic surfactants. Langmuir, 23, 4237-4247.
16. Zhang, C.,Yadava, P., Hughes, J. (2004). Polyethylenimine strategies for plasmid delivery to brain-derived cells. Methods, 33, 144-150.
17. Leong, K.W., Grigsby, C.L. (2010). Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery. J. R. Soc. Interf., 7, S67-S82.
18. Peng, S.F., et al. (2010). Effects of the nanostructure of dendrimer/DNA complexes on their endocytosis and gene expression. Biomaterials, 31, 5660-5670.
19. Tomalia, D.A., et al. (1986). Dendriticmacromolecules-synthesis of starburst dendrimers. Macromolecules, 19, 2466-2468.
20. Tomalia, D.A., et al. (1985). A new class of polymers: starburst-dendritic macromolecules. Polym. J., 17, 117-132.
21. Haensler, J., Szoka, F.C. (1993). Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem., 4, 372-379.
22. Yamagata, M., et al. (2007). Structural advantage of dendritic poly(L-lysine) for gene delivery into cells. Bioorg. Med. Chem., 15, 526-532.
23. Yamamoto, D., Watanabe, S., Miyahara, M.T. (2010). Coordination and reduction processes in the synthesis of dendrimer-encapsulated Pt nanoparticles. Langmuir, 26, 2339-2345.
24. Marano, R.J., et al. (2004). Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. Exp. Eye Res., 79, 525-535.
25. Marano, R.J., et al. (2005). Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity. Gene Ther., 12, 1544-1550.
26. Bermejo, J.F., et al. (2007). Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications. Chemistry, 13, 483-495.
27. Fernandez-Trillo, F., et al. (2008). Fine-tuning the transition temperature of a stimuliresponsive polymer by a simple blending procedure. Chem. Commun. 2230-2232.
28. Posadas, I., et al. (2009). Highly efficient transfection of rat cortical neurons using carbosilane dendrimers unveils a neuroprotective role for HIF-1a in early chemical hypoxia-mediated neurotoxicity. Pharm. Res., 26, 1181-1191.
29. Cena, V., et al. (2007). Lifeguard/neuronal membrane protein 35 regulates FAS ligandmediated apoptosis in neurons via microdomain recruitment. J. Neurochem., 103, 190-203.
30. Ohki, E.C., et al. (2001). Improving the transfection efficiency of post-mitotic neurons. J. Neurosci. Methods, 112, 95-99.
31. Dufes, C., Uchegbu, I.F., Schatzlein, A.G. (2005). Dendrimers in gene delivery. Adv. Drug Delivery Rev., 57, 2177-2202.
32. Fischer, D., et al. (2003). In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials, 24, 1121-1131.
33. Bielinska, A.U., et al. (1999). DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjugate Chem., 10, 843-850.
34. Poxon, S.W., et al. (1996). Dendrimer delivery of oligonucleotides. Drug Deliv., 3, 255-261.
35. Kang, K.A., et al. (2007). Inhibitory effects of glycitein on hydrogen peroxide induced cell damage by scavenging reactive oxygen species and inhibiting c-Jun N-terminal kinase. Free Radic. Res., 41, 720-729.
36. Wu, J., et al. (2005). Polycationic dendrimers interact with RNA molecules: polyamine dendrimers inhibit the catalytic activity of Candida ribozymes. Chem. Commun. 313-315.
37. Malik, N., Evagorou, E.G., Duncan, R. (1999). Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs, 10, 767-776.
38. Gebhart, C.L., Kabanov, A.V. (2001). Evaluation of polyplexes as gene transfer agents. J. Control. Release, 73, 401-416.
39. Zinselmeyer, B.H., et al. (2002). The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm. Res., 19, 960-967.
40. Chisholm, E.J., et al. (2009). Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res., 69, 2655-2662.
41. Koppu, S., et al. (2010). Tumor regression after systemic administration of a novel tumortargeted gene delivery system carrying a therapeutic plasmid DNA. J. Control. Release, 143, 215-221.
42. Ottaviani, M.F., et al. (2000). Formation of supramolecular structures between DNA and starburst dendrimers studied by EPR, CD, UV, and melting profiles. Macromolecules, 33, 7842-7851.
43. Roessler, B.J., et al. (2001). Substituted beta-cyclodextrins interact with PAMAM dendrimer-DNA complexes and modify transfection efficiency. Biochem. Biophys. Res. Commun., 283, 124-129.
44. Su, C.J., et al. (2009). Columnar mesophases of the complexes of DNA with lowgeneration poly(amido amine) dendrimers. Biomacromolecules, 10, 773-783.
45. Evans, H.M., et al. (2003). Structural polymorphism of DNA-dendrimer complexes. Phys. Rev. Lett., 91, 075501.
46. Boeckle, S., et al. (2004). Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J. Gene Med. 6, 1102-1111.
47. Finsinger, D., et al. (2000). Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther., 7, 1183-1192.
48. Clamme, J.P.,Azoulay, J., Mely,Y. (2003).Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys. J., 84, 1960-1968.
49. Eichman, J.D., et al. (2000). The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. Pharm. Sci. Technolo. Today, 3, 232-245.
50. Bolton, K. (2008). Gene delivery with amphiphilic lower generation polypropylenimine dendrimer. In: Pharmaceutical Sciences. University of Strathclide: Glasgow, Scotland.
51. Aggarwal, P., et al. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev., 61, 428-437.
52. Tomalia, D.A., et al. (2003). Structure control within poly(amidoamine) dendrimers: size, shape and regio-chemical mimicry of globular proteins. Tetrahedron, 59, 3799-3813.
53. Chen, W., Turro, N.J., Tomalia, D.A. (2000). Using ethidium bromide to probe the interactions between DNA and dendrimers. Langmuir, 16, 15-19.
54. Nylander, T., et al. (2011). Condensation of DNA using poly(amido amine) dendrimers: effect of salt concentration on aggregate morphology. Soft Matter, 7, 760-768.
55. Carnerup, A.M., et al. (2009). Watching DNA condensation induced by poly(amido amine) dendrimers with time-resolved cryo-TEM. Langmuir, 25, 12466-12470.
56. Schaffer, D.V., et al. (2000).Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng., 67, 598-606.
57. Hollins, A.J., et al. (2004). Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor. Pharm. Res., 21, 458-466.
58. Tang, M.X., Redemann, C.T., Szoka, F.C. Jr., (1996). In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjugate Chem., 7, 703-714.
59. Navarro, G., de Ilarduya, C.T. (2009). Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomedicine, 5, 287-297.
60. Dennig, J., Duncan, E. (2002). Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. Rev. Mol. Biotechnol., 90, 339-347.
61. Navarro, G., et al. (2010). Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. J. Control. Release, 146, 99-105.
62. Ogris, M., et al. (2009). Drug nanocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): imaging fast dynamics of distribution in living animals. Mol. Ther., 17, 1849-1856.
63. Ruthardt, N., et al. (2008). Dynamics of photoinduced endosomal release of polyplexes. J. Control. Release, 130, 175-182.
64. de Jong, G., et al. (2001). Efficient in-vitro transfer of a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers. Chromosome Res., 9, 475-485.
65. Majoros I.J., et al. (2003). Acetylation of poly(amidoamine) dendrimers. Macromolecules, 36, 5526-5529.
66. Fant, K., et al. (2010). Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity and in vitro transfection efficiency. FEBS J., 277, 238-238.
67. Choi, Y., et al. (2004). DNA-directed synthesis of generation 7 and 5 PAMAMdendrimer nanoclusters. Nano Lett., 4, 391-397.
68. Männistö, M., et al. (2002). Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. J. Control. Release, 83, 169-182.
69. Patil, M.L., et al. (2009). Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules, 10, 258-266.
70. Han, L., et al. (2010). Tat-BMPs-PAMAMconjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo. Human Gene Ther., 21, 417-426.
71. Nam, H.Y., et al. (2009). Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity. Biomaterials, 30, 665-673.
72. Tack, F., et al. (2006). Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). J. Drug Target., 14, 69-86.
73. Lee, J.H., et al. (2003). Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconjugate Chem., 14, 1214-1221.
74. Kolhatkar, R.B., et al. (2007). Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjugate Chem., 18, 2054-2060.
75. Holmuhamedov, E.L., et al. (2007). Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules, 8, 3853-3859.
76. Kaminskas, L.M., et al. (2008). The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly L-lysine dendrimers. Mol. Pharm., 5, 449-463.
77. Kim, Y., Klutz, A.M., Jacobson, K.A. (2008). Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. Bioconjugate Chem., 19, 1660-1672.
78. Lee, H., Larson, R.G. (2011). Membrane pore formation induced by acetylated and polyethylene glycol-conjugated polyamidoamine dendrimers. J. Phys. Chem. C, 115, 5316-5322.
79. Tomalia, D.A., Reyna, L.A., Svenson, S. (2007). Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans., 35, 61-67.
80. Braun, C.S., et al. (2005). Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J. Pharm. Sci., 94, 423-436.
81. Kim, T.I., et al. (2007). Synthesis and characterization of a novel arginine-grafted dendritic block copolymer for gene delivery and study of its cellular uptake pathway leading to transfection. Bioconjugate Chem., 18, 309-317.
82. Kim, T.I., et al. (2007). Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials, 28, 2061-2067.
83. Chaltin, P., et al. (2005). Delivery of antisense oligonucleotides using cholesterolmodified sense dendrimers and cationic lipids. Bioconjugate Chem., 16, 827-836.
84. Bijsterbosch, M.K., et al. (2002). bis-Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides are highly selectively taken up by the liver. J. Pharmacol. Exp. Ther., 302, 619-626.
85. Yoo, H., Juliano, R.L. (2000). Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res., 28, 4225-4231.
86. Kono, K., et al. (2005). Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery. Bioconjugate Chem., 16, 208-214.
87. Yoo, H., et al. (2008). Preparation and evaluation of cholesteryl PAMAM dendrimers as nano delivery agents for antisense oligonucleotides. Colloid. Surface. A, 313, 273-277.
88. Arima, H., et al. (2001). Enhancement of gene expression by polyamidoamine dendrimer conjugates with a-, b-, and g-cyclodextrins. Bioconjugate Chem., 12, 476-484.
89. Tsutsumi, T., et al. (2007). Evaluation of polyamidoamine dendrimer/a-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA). J. Control. Release, 119, 349-359.
90. Kihara, F., et al. (2003). In vitro and in vivo gene transfer by an optimized a-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjugate Chem., 14, 342-350.
91. van Duijvenbode, R.C., Borkovec, M.,Koper, G.J.M. (1998). Acid-base properties of poly (propylene imine) dendrimers. Polymer, 39, 2657-2664.
92. Santander-Ortega, M.J., Uchegbu, I.F., Schätzlein, A.G.unpublished data.
93. Kabanov V.A., et al. (1999). Interaction of astramol poly(propyleneimine) dendrimers with linear polyanions. Macromolecules, 32, 1904-1909.
94. Kaneshiro, T.L., Lu, Z.R. (2009). Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. Biomaterials, 30, 5660-5666.
95. Sun, J., et al. (2008). Surface properties of a series of amphiphilic dendrimers with short hydrophobic chains. Langmuir, 24, 1858-1862.
96. Zhang, N., Liu, C.X. (2009). Pharmaceutical strategies enhancing cell penetration efficiencies of non-viral gene delivery systems. Curr. Gene Ther., 9, 267-290.
97. Conner, S.D., Schmid, S.L. (2003). Regulated portals of entry into the cell. Nature, 422, 37-44.
98. Perumal, O.P., et al. (2008). The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials, 29, 3469-3476.
99. Parton, R.G., Simons, K. (2007). The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol., 8, 185-194.
100. Vohs, J.K., et al. (2004). Low-temperature growth of carbon nanotubes from the catalytic decomposition of carbon tetrachloride. J. Am. Chem. Soc., 126, 9936-9937.
101. Simons, K., Ikonen, E. (1997). Functional rafts in cell membranes. Nature, 387, 569-572.
102. Norkin, L.C.,Wolfrom, S.A., Stuart, E.S. (2001). Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection. Exp. Cell Res., 266, 229-238.
103. Pelkmans, L., Kartenbeck, J., Helenius, A. (2001). Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nature Cell Biol., 3, 473-483.
104. Peyron, P., et al. (2000). Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. J. Immunol., 165, 5186-5191.
105. Varma, R., Mayor, S. (1998). GPI-anchored proteins are organized in submicron domains at the cell surface. Nature, 394, 798-801.
106. Manunta, M., et al. (2004). Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res., 32, 2730-2739.
107. Schitzer, J.E., et al. (1994). Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis and capillary permeability of select macromolecules. J. Cell Biol., 127, 1217-1232.
108. Damke, H., et al. (1995). Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin. J. Cell Biol., 131, 69-80.
109. Ohkuma, S., Poole, B. (1978). Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. U.S.A., 75, 3327-3331.
110. Nishikawa, K., et al. (2002). A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157: H7. Proc. Natl. Acad. Sci. U.S.A., 99, 7669-7674.
111. Juliano, R., et al. (2008). Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res., 36, 4158-4171.
112. Cho, Y.W., Kim, J.D., Park, K. (2003). Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol., 55, 721-734.
113. Sonawane, N.D., Szoka, F.C.,Verkman, A.S. (2003). Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem., 278, 44826-44831.
114. Behr, J.P. (1994). Gene-transfer with synthetic cationic amphiphiles-prospects for gene therapy. Bioconjugate Chem., 5, 382-389.
115. Huth, S., et al. (2006). Interaction of polyamine gene vectors with RNA leads to the dissociation of plasmid DNA-carrier complexes. J. Gene Med. 8, 1416-1424.
116. Thomas, M., Klibanov, A.M. (2003). Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol, 62, 27-34.
117. Fainerman, V.B., et al. Langmuir, 26 (4): 2424-2429.
118. Lechardeur, D., et al. (1999). Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther., 6, 482-497.
119. Cushing, D.J., et al. (2010). Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. Eur. J. Pharmacol., 635, 165-170.
120. Glover, D.J. et al. (2010). The efficiency of nuclear plasmid DNA delivery is a critical determinant of transgene expression at the single cell level. J. Gene Med. 12, 77-85.
121. Kihara, F., et al. (2002). Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with a-cyclodextrin. Bioconjugate Chem., 13, 1211-1219.
122. Pouton, C.W., Seymour, L.W. (2001). Key issues in non-viral gene delivery. Adv. Drug Delivery Rev., 46, 187-203.
123. Godbey, W.T., Wu, K.K., Mikos, A.G. (1999). Tracking the intracellular path of poly (ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. U.S.A, 96, 5177-5181.
124. Kreiss, P., et al. (1999). Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res., 27, 3792-3798.
125. Brunner, S., et al. (2000). Cell cycle dependence of gene transfer by lipoplex polyplex and recombinant adenovirus. Gene Ther., 7, 401-407.
126. Wilke, M., et al. (1996). Efficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Ther., 3, 1133-1142.
127. Lam, A.P., Dean, D.A. (2010). Progress and prospects: nuclear import of nonviral vectors. Gene Ther., 17, 439-447.
128. Munkonge, F.M., et al. (2009). Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import. J. Biol. Chem., 284, 26978-26987.
129. Featherstone, C., Darby, M.K., Gerace, L. (1988). A monoclonal antibody against the nuclear pore complex inhibits nucleocytoplasmic transport of protein and RNA in vivo. J. Cell Biol., 107, 1289-1297.
130. Dowty, M.E., et al. (1995). Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc. Natl. Acad. Sci. U.S.A, 92, 4572-4576.
131. Pollard, H., et al. (1998). Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J. Biol. Chem., 273, 7507-7511.
132. Gene Therapy Clinical Trials Worldwide. 2011 [cited 2011 30/08/2011]; Available at: http://www.wiley.com/legacy/wileychi/genmed/clinical/.
133. Moghimi, S.M., Bonnemain, B. (1999). Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. Adv Drug Deliv Rev, 37, 295-312.
134. Cassidy, J., Schatzlein, A.G. (2004). Tumour-targeted drug and gene delivery: principles and concepts. Expert Rev Mol Med, 6, 1-17.
135. Abdelhady, H.G., et al. (2003). Direct real-time molecular scale visualisation of the degradation of condensed DNA complexes exposed to DNase I. Nucleic Acids Res, 31, 4001-4005.
136. Rugheimer, L., Hansell, P.,Wolgast, M. (2008). Determination of the charge of the plasma proteins and consequent Donnan equilibrium across the capillary barriers in the rat microvasculature. Acta physiologica, 194, 335-339.
137. Santander-Ortega, M.J., Bastos-Gonzalez, D., Ortega-Vinuesa, J.L. (2007). Electrophoretic mobility and colloidal stability of PLGA particles coated with IgG. Colloid. Surf. B-Biointerfaces, 60, 80-88.
138. Ortega-Vinuesa, J.L., Hidalgo-Alvarez, R. (1995). Sequential adsorption of F(ab0)(2) and BSA on negatively and positively charged polystyrene latexes. Biotechnol. Bioeng., 47, 633-639.
139. Tirado-Miranda, M., et al. (2003). The aggregation behaviour of protein-coated particles: a light scattering study. Eur Biophys J, 32, 128-136.
140. Kukowska-Latallo, J.F., et al. (2000). Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector. Human Gene Ther., 11, 1385-1395.
141. Moghimi, S.M., et al. (1993). An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim. Biophys. Acta., 1157, 233-240.
142. Hellstrand, E., et al. (2009). Complete high-density lipoproteins in nanoparticle corona. FEBS J, 276, 3372-3381.
143. Dagher, G., et al. (2003). HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes. J. Lipid Res., 44, 1811-1820.
144. Zhang, Y., et al. (2007). The inhibition of endocytosis affects HDL-lipid uptake mediated by the human scavenger receptor class B type I. Mol. Membrane Biol., 24, 442-454.
145. Kim, H.R., et al. (2007). Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. Cell. Mol. Life Sci., 64, 356-364.
146. Santander-Ortega, M.J., et al. (2006). Colloidal stability of Pluronic F68-coated PLGA nanoparticles:Avariety of stabilisation mechanisms. J. Colloid Interf. Sci., 302, 522-529.
147. Woodle, M.C., Newman, M.S., Martin, F.J. (1992). Liposome leakage and bloodcirculation- comparison of adsorbed block copolymers with covalent attachment of peg. Int. J. Pharm., 88, 327-334.
148. Allen, T.M., Cullis, P.R. (2004). Drug delivery systems: Entering the mainstream. Science, 303, 1818-1822.
149. Dobrovolskaia, M.A., McNeil, S.E. (2007). Immunological properties of engineered nanomaterials. Nat Nanotechnol, 2, 469-478.
150. Dash, B.C., et al. (2010). The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility. Biomaterials, 31, 8188-8197.
151. Dobrovolskaia, M.A., et al. (2009). Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine, 5, 106-117.
152. Fortina, P., et al. (2005). Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol, 23, 168-173.
153. Vincent, L., et al. (2003). Efficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis: in vitro and in vivo studies. Int. J. Cancer, 105, 419-429.
154. Percec V., et al. (2010). Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures. Science, 328, 1009-1014.
155. Herweijer H., Wolff J.A. (2003). Gene Ther., 10, 453-458.
156. Morille, M., et al. (2008). Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials, 29, 3477-3496.
157. Chisholm, E.J., et al. (2009). Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res, 69, 2655-2662.
158. Cerritelli S., Velluto D., Hubbell J.A. (2007). PEG-SS-PSS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules, 8, 1966-1972.
159. Zinselmeyer, B.H., et al. (2002). The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm. Res., 19, 960-967.
160. Calzolari, A., et al. (2007). Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Molecules and Diseases, 39, 82-91.
161. Huang, R.Q., et al. (2007). Efficient gene delivery targeted to the brain using a transferrinconjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J., 21, 1117-1125.
162. Ke, W., et al. (2009). Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials, 30, 6976-6985.
163. Liu, Y., et al. (2009), Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials, 30, 4195-4202.
164. Liu, Y., et al. (2010) A leptin derived 30-amino-acid peptide modified pegylated poly-Llysine dendrigraft for brain targeted gene delivery. Biomaterials, 31, 5246-5257.
165. Taratula, O., et al. (2009) Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release., 140, 284-293.